Skip to main content

Table 2 Vitiligo Area Scoring Index (VASI) and its correlation with demographic characteristic of patients with vitiligo

From: Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)

  

N

Mean of VASI

Standard deviation of VASI

Median of VASI

P value

Total

 

173

8.62

13.09

3.8

 

Treatment group

General Clinic

93

6.08

8.44

1.87

0.04

 

Phototherapy Clinic

80

8.70

9.09

6.02

Gender

Female

84

9.50

14.63

4.44

0.2

Male

89

7.80

11.43

3.18

Age

16–19

28

6.96

9.36

1.71

0.1

20–29

49

7.71

11.86

4.38

30–39

56

7.56

11.85

3.13

> = 40

40

12.38

17.47

6.7

Disease duration (years)

<5

63

3.61

5.56

1.54

<0.001

5- < 10

33

7.96

8.97

3.75

10- < 15

37

11.10

14.78

4.56

15- < 20

13

15.34

10.70

12.87

> = 20

27

14.46

21.87

6.55

Education

Illiterate

4

19.39

11.77

17.62

0.009

Grade 1–11

44

10.54

16.01

6.33

Grade 12

76

9.12

13.68

3.22

University education

49

5.24

7.63

2.80

Skin phototype (Fitzpatrick scale)

1,2

4

3.97

11.77

1.64

0.2

3,4

153

8.46

13.32

3.75

5,6

16

11.32

12.17

4.94

Type of disease

Generalized

148

9.92

13.73

5.54

<0.001

Localized

15

0.77

1.35

0.30

Segmental

10

0.95

1.28

0.40

Disease progression

Improving

82

7.49

8.51

4.90

0.6

No change

33

11.11

21.40

3.42

Slowly progressive

40

10.13

13.82

3.87

Rapidly progressive

18

5.81

7.55

1.84

Response to treatment

Poor

50

6.69

7.41

3.31

0.4

Moderate

53

8.06

10.88

5.58

Appropriate

65

10.92

17.59

4.19

No treatmenta

5

3.84

6.58

0.33

Previous or current psychiatric disease

Yes

17

7.33

8.99

3.42

0.99

No

156

8.76

13.48

4.25

Another visible skin disorder other than vitiligo

Yes

9

2.52

2.76

1.59

0.04

No

164

8.95

13.48

4.25

  1. aPatients who were not on any treatment